| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $247.3M | +13.3% |
| Cost of Revenue | $41.9M | +0.6% |
| R&D Expense | $127.9M | -14.7% |
| SG&A Expense | $92.1M | +21.2% |
| Operating Income | -$121.6M | +29.4% |
| Pre-tax Income | -$97.4M | +33.8% |
| Income Tax | $706K | -6.6% |
| Net Income | -$98.1M | +33.6% |
| EPS (Basic) | -$0.25 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.5M | -24.4% |
| Accounts Receivable | $31.2M | +18.8% |
| Current Assets | $466.7M | -17.7% |
| Total Assets | $514.0M | -21.5% |
| Current Liabilities | $27.9M | -21.1% |
| Total Liabilities | $60.5M | -37.0% |
| Stockholders' Equity | $453.5M | -18.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.2M | +65.9% |
| Capital Expenditures | $404K | +51.3% |
| Investing Cash Flow | $86.4M | +30.0% |
| Financing Cash Flow | -$81.0M | -1008.9% |
| Free Cash Flow | -$20.6M | +65.4% |
| +35.9% |
| EPS (Diluted) | -$0.25 | +35.9% |